Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership
Twenty per cent of the UK population are living with, or are at risk of, type 2 diabetes (T2D), with estimated annual NHS treatment costs of £8.8 billion. This rising tide identifies an urgent need to reduce uncertainties around the causes, prevention, and treatment of T2D. A patient-centred appro...
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2017
|
_version_ | 1797056024579932160 |
---|---|
author | Finer, S Robb, P Cowan, K Daly, A Robertson, E Farmer, A |
author_facet | Finer, S Robb, P Cowan, K Daly, A Robertson, E Farmer, A |
author_sort | Finer, S |
collection | OXFORD |
description | Twenty per cent of the UK population are living with, or are at risk of, type 2 diabetes (T2D), with estimated annual NHS treatment costs of £8.8 billion. This rising tide identifies an urgent need to reduce uncertainties around the causes, prevention, and treatment of T2D. A patient-centred approach is a cornerstone of high quality diabetes care and is mirrored in research by an increasing focus on patient and public involvement. The James Lind Alliance (JLA) has a 13-year history of collaboration with patients, carers and clinicians identifying and prioritising unmet research needs to drive improvements in clinical care. A Priority Setting Partnership (PSP) was set up in 2015 by Diabetes UK and the JLA to identify key priorities for future T2D research. |
first_indexed | 2024-03-06T19:17:30Z |
format | Journal article |
id | oxford-uuid:18e868ed-2dfc-412e-935c-64f9b3cbfa68 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T19:17:30Z |
publishDate | 2017 |
publisher | Elsevier |
record_format | dspace |
spelling | oxford-uuid:18e868ed-2dfc-412e-935c-64f9b3cbfa682022-03-26T10:45:53ZTop ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting PartnershipJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:18e868ed-2dfc-412e-935c-64f9b3cbfa68EnglishSymplectic Elements at OxfordElsevier2017Finer, SRobb, PCowan, KDaly, ARobertson, EFarmer, ATwenty per cent of the UK population are living with, or are at risk of, type 2 diabetes (T2D), with estimated annual NHS treatment costs of £8.8 billion. This rising tide identifies an urgent need to reduce uncertainties around the causes, prevention, and treatment of T2D. A patient-centred approach is a cornerstone of high quality diabetes care and is mirrored in research by an increasing focus on patient and public involvement. The James Lind Alliance (JLA) has a 13-year history of collaboration with patients, carers and clinicians identifying and prioritising unmet research needs to drive improvements in clinical care. A Priority Setting Partnership (PSP) was set up in 2015 by Diabetes UK and the JLA to identify key priorities for future T2D research. |
spellingShingle | Finer, S Robb, P Cowan, K Daly, A Robertson, E Farmer, A Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership |
title | Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership |
title_full | Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership |
title_fullStr | Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership |
title_full_unstemmed | Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership |
title_short | Top ten research priorities for type 2 diabetes: results from the Diabetes UK-James Lind Alliance Priority Setting Partnership |
title_sort | top ten research priorities for type 2 diabetes results from the diabetes uk james lind alliance priority setting partnership |
work_keys_str_mv | AT finers toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership AT robbp toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership AT cowank toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership AT dalya toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership AT robertsone toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership AT farmera toptenresearchprioritiesfortype2diabetesresultsfromthediabetesukjameslindallianceprioritysettingpartnership |